CRISPR Therapeutics AG Income Statement
CRSP / Health Care|12 years of annual SEC 10-K data (FY2014-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 12 fiscal years. All figures from audited SEC 10-K filings.
CRISPR Therapeutics AG reported $4M in revenue and $582M in net loss for FY2025. Revenue has grown at a 30.4% compound annual rate over the past 10 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.5M | $37.3M | $371.2M | $1.2M | $915.0M | $719.0K | $328.0K | $3.1M | $41.0M | $5.2M | $247.0K | - |
| SG&A Expense | $73.5M | $73.0M | $76.2M | $102.5M | $99.7M | $85.7M | $63.5M | $48.3M | $35.8M | $31.1M | $13.4M | $5.1M |
| R&D Expense | $284.8M | $310.2M | $387.3M | $461.6M | $340.6M | $221.4M | $179.4M | $113.8M | $69.8M | $42.2M | $12.6M | $1.5M |
| Operating Income | -$664.6M | -$466.6M | -$222.5M | -$673.2M | $373.5M | -$354.4M | $46.7M | -$158.9M | -$64.6M | -$68.1M | -$25.7M | -$6.6M |
| Income Tax | $3.6M | $3.6M | $2.9M | -$325.0K | $1.9M | $809.0K | $448.0K | $553.0K | $1.7M | $484.0K | $7.0K | -$63.0K |
| Net Income | -$581.6M | -$366.3M | -$153.6M | -$650.2M | $377.7M | -$348.9M | $66.9M | -$165.0M | -$68.4M | -$23.2M | -$25.5M | -$7.0M |
| EPS (Basic) | -$1.94 | -$8.36 | $4.97 | -$5.29 | $1.23 | -$3.44 | -$1.71 | -$0.62 | -$0.54 | -$1.53 | - | - |
| EPS (Diluted) | -$1.94 | -$8.36 | $4.70 | -$5.29 | $1.17 | -$3.44 | -$1.71 | -$0.62 | -$0.54 | -$1.53 | - | - |
| Shares Outstanding | 85.7M | 80.0M | 78.5M | 77.0M | 73.9M | 60.8M | 51.9M | 40.6M | 39.7M | 5.5M | 5.0M | 3.6M |
| Operating Margin | -18933.7% | -1250.4% | -60.0% | -56190.4% | 40.8% | -49295.5% | 14250.0% | -5087.8% | -157.7% | -1319.3% | - | - |
| Profit Margin | -16569.8% | -981.5% | -41.4% | -54271.7% | 41.3% | -48520.9% | 20383.5% | -5281.1% | -166.7% | -448.8% | - | - |